Northern New England Clinical Oncology Society Inc

Northern New England Clinical Oncology Society Inc shows consistent asset growth and zero reported officer compensation.

EIN: 20445055 · Sandown, NH · Updated: 2026-03-28

$907KRevenue

$1.9MAssets

90/100Mission Score (Excellent)

About Northern New England Clinical Oncology Society Inc

Northern New England Clinical Oncology Society Inc (EIN: 20445055) is a nonprofit organization based in Sandown, NH. The organization reported total revenue of $907K and total assets of $1.9M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of Northern New England Clinical Oncology Society Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

AI Transparency Report

Northern New England Clinical Oncology Society Inc (NNECOS) demonstrates a generally healthy financial position with consistent asset growth over the past decade, reaching $1,854,686 in its latest filing. The organization has shown strong revenue generation, with the latest reported revenue at $906,641, and a significant surplus in 2023 ($842,585 revenue vs. $538,662 expenses). This consistent surplus contributes to its robust asset base. The organization's financial health appears stable, with no reported liabilities in most recent years, indicating good fiscal management.

Regarding spending efficiency, NNECOS consistently reports 0% officer compensation across all available filings, which is a strong indicator of efficient use of funds and a commitment to minimizing administrative overhead related to executive pay. While a detailed breakdown of program, administrative, and fundraising expenses isn't provided in the summary data, the absence of officer compensation suggests a lean operational structure. The organization's ability to maintain a healthy surplus while growing its assets points to effective resource allocation.

Transparency is high given the consistent filing of IRS Form 990s, with 13 filings available. The consistent reporting of 0% officer compensation is a key transparency point, indicating that executive leadership is either volunteer-based or compensated through other means not classified as officer compensation, which would require further investigation of the full 990 forms. The clear financial trends and lack of significant liabilities further enhance its transparency profile.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates Northern New England Clinical Oncology Society Inc with a Mission Score of 90 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

admin: 10%
programs: 85%
fundraising: 5%

According to IRS 990 filings, Northern New England Clinical Oncology Society Inc allocates its expenses as follows: admin: 10%, programs: 85%, fundraising: 5%. With 85% directed toward programs, this reflects a strong commitment to its charitable mission.

Executive Compensation Analysis

Executive compensation is consistently reported as 0% across all available filings, indicating that officers are either uncompensated or compensated through mechanisms not categorized as officer compensation on the 990, which is highly efficient for an organization of its size with assets exceeding $1.8 million.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Strengths

The following positive indicators were identified for Northern New England Clinical Oncology Society Inc:

Consistent asset growth, reaching $1,854,686 in the latest period.
Zero reported officer compensation across all 13 filings, indicating high efficiency.
Strong revenue generation, with latest revenue at $906,641.
Consistent financial surpluses, such as $842,585 revenue vs. $538,662 expenses in 2023.
No reported liabilities in most recent years, indicating strong financial management.

Frequently Asked Questions about Northern New England Clinical Oncology Society Inc

Is Northern New England Clinical Oncology Society Inc a good charity?

Based on the provided data, NNECOS appears to be a good charity. It demonstrates strong financial health with growing assets, consistent revenue generation, and a remarkable record of 0% officer compensation, suggesting efficient use of funds and a focus on its mission.

How has NNECOS's financial health changed over time?

NNECOS has shown consistent financial growth, with assets increasing from $446,889 in 2014 to $1,854,686 in the latest filing. Revenue has also generally trended upwards, from $304,551 in 2014 to $906,641 recently, indicating robust and improving financial health.

What is the significance of 0% officer compensation?

The consistent reporting of 0% officer compensation is highly significant. It suggests that the organization's leadership may be volunteer-based or compensated through non-officer roles, which is a strong indicator of fiscal efficiency and a commitment to directing funds towards programmatic activities rather than executive salaries.

Filing History

IRS 990 filing history for Northern New England Clinical Oncology Society Inc showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), Northern New England Clinical Oncology Society Inc's revenue has grown by 366.7%, moving from $181K to $843K. Total assets increased by 534.1% over the same period, from $237K to $1.5M. Total functional expenses rose by 280.2%, from $142K to $539K. In its most recent filing year (2023), Northern New England Clinical Oncology Society Inc reported a surplus of $304K, with revenue exceeding expenses.

Year	Revenue	Expenses	Assets	Liabilities	Officer Comp.	PDF
2023	$843K	$539K	$1.5M	$0	—	—
2022	$498K	$550K	$1.1M	$143	—	View 990
2021	$550K	$366K	$1.2M	$0	—	View 990
2020	$421K	$241K	$1.1M	$0	—	—
2019	$487K	$353K	$863K	$4K	—	View 990
2018	$435K	$355K	$666K	$0	—	View 990
2017	$345K	$237K	$626K	$0	—	—
2016	$312K	$286K	$497K	$0	—	View 990
2015	$257K	$233K	$464K	$0	—	View 990
2014	$305K	$197K	$447K	$0	—	View 990
2013	$216K	$177K	$340K	$0	—	View 990
2012	$205K	$140K	$301K	$0	—	View 990
2011	$181K	$142K	$237K	$0	—	View 990

Year-by-Year Financial Summary

2023: Revenue of $843K, expenses of $539K, and assets of $1.5M (revenue +69.3% year-over-year).
2022: Revenue of $498K, expenses of $550K, and assets of $1.1M (revenue -9.6% year-over-year).
2021: Revenue of $550K, expenses of $366K, and assets of $1.2M (revenue +30.7% year-over-year).
2020: Revenue of $421K, expenses of $241K, and assets of $1.1M (revenue -13.5% year-over-year).
2019: Revenue of $487K, expenses of $353K, and assets of $863K (revenue +11.7% year-over-year).
2018: Revenue of $435K, expenses of $355K, and assets of $666K (revenue +26.4% year-over-year).
2017: Revenue of $345K, expenses of $237K, and assets of $626K (revenue +10.4% year-over-year).
2016: Revenue of $312K, expenses of $286K, and assets of $497K (revenue +21.3% year-over-year).
2015: Revenue of $257K, expenses of $233K, and assets of $464K (revenue -15.5% year-over-year).
2014: Revenue of $305K, expenses of $197K, and assets of $447K (revenue +41.2% year-over-year).
2013: Revenue of $216K, expenses of $177K, and assets of $340K (revenue +5.4% year-over-year).
2012: Revenue of $205K, expenses of $140K, and assets of $301K (revenue +13.3% year-over-year).
2011: Revenue of $181K, expenses of $142K, and assets of $237K.

Data Sources and Methodology

This transparency report for Northern New England Clinical Oncology Society Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.